Dual-targeted disease-modifying therapies for osteoarthritis

Lancet. 2024 Jun 15;403(10444):2591. doi: 10.1016/S0140-6736(24)00475-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Humans
  • Osteoarthritis* / drug therapy

Substances

  • Antirheumatic Agents